Stay updated on Lebrikizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy and safety evaluation of Lebrikizumab in patients with moderate to severe atopic dermatitis in a clinical trial.
    Difference
    0.1%
    Check dated 2024-06-06T14:51:08.000Z thumbnail image
  6. Check
    20 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' which includes examples such as a person's general health condition or prior treatments. This change provides a more detailed explanation of what eligibility criteria entail.
    Difference
    17%
    Check dated 2024-05-22T21:38:01.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:28:44.000Z thumbnail image

Stay in the know with updates to Lebrikizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.